Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart.
D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy* / Q000517:prevention & control*; D003964:Diaphragm / Q000187:drug effects / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism*; D005998:Glycine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007773:Lactates / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism*; D051381:Rats
D005227:Fatty Acids; D007773:Lactates; D011768:Pyruvate Dehydrogenase Complex; C023010:4-hydroxyphenylglycine; D005998:Glycine